Absorption |
Blood-Brain Barrier | BBB+ | 0.9800 |
Human Intestinal Absorption | HIA+ | 0.9956 |
Caco-2 Permeability | Caco2+ | 0.7200 |
P-glycoprotein Substrate | Non-substrate | 0.8097 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9201 |
Non-inhibitor | 0.9726 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8581 |
Distribution |
Subcellular localization | Mitochondria | 0.4925 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8454 |
CYP450 2D6 Substrate | Non-substrate | 0.7679 |
CYP450 3A4 Substrate | Non-substrate | 0.6949 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8890 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7903 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9174 |
CYP450 2C19 Inhibitor | Inhibitor | 0.7076 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8245 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7152 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9394 |
Non-inhibitor | 0.9389 |
AMES Toxicity | Non AMES toxic | 0.8841 |
Carcinogens | Non-carcinogens | 0.6594 |
Fish Toxicity | High FHMT | 0.6314 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9822 |
Honey Bee Toxicity | Low HBT | 0.6539 |
Biodegradation | Ready biodegradable | 0.8259 |
Acute Oral Toxicity | III | 0.6977 |
Carcinogenicity (Three-class) | Non-required | 0.4985 |